文献速递脑血管病外科

美国全国住院患者样本中未破裂脑动静脉畸形的显微外科治疗在ARUBA试验后更常见

Microsurgery for Unruptured Cerebral Arteriovenous Malformations in the National Inpatient Sample is More Common Post-ARUBA.
PubMed 文献 · World Neurosurg · 2020-02-04

该研究利用美国全国住院患者样本(National Inpatient Sample)分析未破裂脑动静脉畸形(cAVM)的治疗趋势,以2013年5月欧洲卒中会议报告和2014年2月《柳叶刀》发表ARUBA试验结果为时间节点。结果显示两个时间点后未破裂cAVM总体治疗率下降,但单纯手术切除相对于其他方式的比例显著增加,血管内介入呈非显著性下降。作者认为ARUBA试验影响了美国未破裂cAVM的治疗模式。

要点

  • 两个ARUBA时间点后未破裂cAVM总体治疗率均下降。
  • 单纯手术切除相对于其他治疗方式的比例显著增加。
  • 血管内介入治疗呈非显著性下降。

核心结论

  • 作者认为ARUBA试验影响了美国未破裂cAVM的治疗模式,尽管总体治疗率下降,ARUBA后接受治疗的未破裂cAVM最常采用单纯手术切除。

研究设计与样本

  • 利用美国全国住院患者样本(National Inpatient Sample,美国最大的全支付方住院医疗数据库),筛选因cAVM治疗择期入院的患者,确定其所接受的治疗方式。
  • 队列分别以两个ARUBA时间点进行二分:2013年5月欧洲卒中会议报告和2014年2月《柳叶刀》发表。

主要发现

  • 两个时间点后未破裂cAVM的总体治疗率均下降。
  • 单纯手术切除相对于其他治疗方式的比例显著增加。
  • 血管内介入呈现非显著性下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ARUBA trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformations) was the first randomized control trial to investigate unruptured cerebral arteriovenous malformation (cAVM) treatments and concluded that medical management was superior to interventional therapy for the treatment of unruptured cAVMs. This conclusion generated considerable controversy and was followed by rebuttals and meta-analyses of the ARUBA methodology and results. We sought to determine whether the ARUBA results altered treatment trends of cAVMs within the United States. METHODS: Using the National Inpatient Sample, the largest all-payer inpatient care database within the United States, we isolated patients who were admitted on an elective basis for cAVM treatment and determined the treatment modality undergone by these patients. The cohort was dichotomized separately at 2 ARUBA time points: the European Stroke Conference presentation in May 2013, and The Lancet publication in February 2014. RESULTS: We found that the overall treatment rate of unruptured cAVMs decreased after both time points. However, the rate of surgical excision alone, relative to other modalities, was significantly increased, and endovascular intervention demonstrated a nonsignificant decrease. CONCLUSIONS: Our findings suggest that the ARUBA trial has influenced unruptured cAVM treatment patterns within the United States. Although the overall treatment rate has decreased, unruptured cAVMs, when treated post-ARUBA, are most commonly approached with surgical excision alone.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Birnbaum LA, Straight M, Hegde S, et al. Microsurgery for Unruptured Cerebral Arteriovenous Malformations in the National Inpatient Sample is More Common Post-ARUBA. World Neurosurg. 2020. PMID: 32032786. doi:10.1016/j.wneu.2020.01.211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。